Cargando…
On-demand cell-autonomous gene therapy for brain circuit disorders
Several neurodevelopmental and neuropsychiatric disorders are characterized by intermittent episodes of pathological activity. Although genetic therapies offer the ability to modulate neuronal excitability, a limiting factor is that they do not discriminate between neurons involved in circuit pathol...
Autores principales: | Qiu, Yichen, O’Neill, Nathanael, Maffei, Benito, Zourray, Clara, Almacellas-Barbanoj, Amanda, Carpenter, Jenna C., Jones, Steffan P., Leite, Marco, Turner, Thomas J., Moreira, Francisco C., Snowball, Albert, Shekh-Ahmad, Tawfeeq, Magloire, Vincent, Barral, Serena, Kurian, Manju A., Walker, Matthew C., Schorge, Stephanie, Kullmann, Dimitri M., Lignani, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613996/ https://www.ncbi.nlm.nih.gov/pubmed/36378958 http://dx.doi.org/10.1126/science.abq6656 |
Ejemplares similares
-
Electrophysiological Properties of Human Cortical Organoids: Current State of the Art and Future Directions
por: Zourray, Clara, et al.
Publicado: (2022) -
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
por: Turner, Thomas J., et al.
Publicado: (2020) -
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
por: Colasante, Gaia, et al.
Publicado: (2020) -
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
por: Weston, Mikail, et al.
Publicado: (2019) -
Activity Clamp Provides Insights into Paradoxical Effects of the Anti-Seizure Drug Carbamazepine
por: Morris, Gareth, et al.
Publicado: (2017)